LumiraDx earnings beat by 0.07, revenue fell short of estimates
LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Slightly above 61% of LumiraDx's investor base is looking to short. The analysis of current outlook of investing in LumiraDx suggests that many traders are alarmed regarding LumiraDx's prospects. LumiraDx's investing sentiment can be driven by a variety of factors including economic data, LumiraDx's earnings reports, geopolitical events, and overall market trends.
LumiraDx |
LumiraDx earnings beat by 0.07, revenue fell short of estimates
Read at investing.com
LumiraDx Fundamental Analysis
We analyze LumiraDx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LumiraDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LumiraDx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
LumiraDx is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
LumiraDx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LumiraDx stock to make a market-neutral strategy. Peer analysis of LumiraDx could also be used in its relative valuation, which is a method of valuing LumiraDx by comparing valuation metrics with similar companies.
Peers
LumiraDx Related Equities
SHC | Sotera Health | 1.65 | ||||
XGN | Exagen | 1.41 | ||||
FONR | Fonar | 0.87 | ||||
BDSX | Biodesix | 0.68 | ||||
BNR | Burning Rock | 1.22 | ||||
ENZ | Enzo Biochem | 1.35 | ||||
SERA | Sera Prognostics | 7.56 | ||||
DRIO | DarioHealth Corp | 12.50 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |